ClinicalTrials.Veeva

Menu

Role of Coenzyme Q in ADHD in Children

S

Sherief Abd-Elsalam

Status and phase

Enrolling
Phase 3

Conditions

ADHD

Treatments

Drug: Coenzyme Q
Drug: Atomoxetine

Study type

Interventional

Funder types

Other

Identifiers

NCT04216186
abeer salamah

Details and patient eligibility

About

Role of Coenzyme Q in ADHD in Children

Full description

Role of Coenzyme Q in ADHD in Children: will it add a benefit?

Enrollment

40 estimated patients

Sex

All

Ages

2 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with ADHD

Exclusion criteria

  • Comorbidities like Autism, Anxiety, Obsessive compulsive disorder.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

40 participants in 2 patient groups, including a placebo group

Atomoxetine and Coenzyme Q
Active Comparator group
Description:
Atomoxetine and Coenzyme Q
Treatment:
Drug: Coenzyme Q
Drug: Atomoxetine
Placebo and Atomoxetine
Placebo Comparator group
Description:
Placebo and Coenzyme Q
Treatment:
Drug: Coenzyme Q

Trial contacts and locations

1

Loading...

Central trial contact

Sherief Abd-Elsalam, ass. prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems